BioReference makes acquisition, establishes West Coast presence

|By:, SA News Editor

BioReference Laboratories (BRLI +2%) acquires most of Hunter Laboratories' assets, giving BRLI a West Cost presence and Medi-Cal in-network status.

"Having a local base for operations can provide significant operational and logistical synergies," CEO Marc Grodman notes. (PR)

Shares of Neogenomics (NEO -7.8%), a notable peer, are off sharply on the session.